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Abstract: In this time of an aging population in the Western world and a concomitant need 
for cost reduction, there is an obvious need for innovative health care delivery. One of the 
consequences is that a growing number of telemedicine applications are emerging in different 
health care domains. Also in the area of speech-language (SL) disorders, particularly neurogenic 
disorders, telemedicine is rapidly gaining interest. In this paper, we place applications for neuro-
genic SL disorders in a telemedicine taxonomy in order to establish common features along the 
dimensions of functionality, application, and technology, and their components. Thus, we aim 
at identifying common features in a wide variety of telemedicine applications and to establish 
common interests of stakeholders in health care for classified groups of telemedicine applications. 
This may facilitate decision-making with regard to expansion of innovative products, and give 
directions to measures needed for upscaling and structural embedding of feasible and effective 
SL telemedicine applications in health care. Common interests of stakeholders in health care, 
established using telemedicine taxonomy, is a key factor in decision-making with regard to 
which telemedicine applications should be given priority for genuine utilization. Priorities of 
health care institutions, patients, and reimbursement companies are also leading for research-
ers aiming at solid scientific evidence for the beneficial effects of target applications. That is, 
although research results tend to indicate the potential of telemedicine in the area of SL pathol-
ogy, the alleged benefits of most applications have not been confirmed according to the accepted 
standards for clinical outcome testing as yet. Methodologic obstacles and the lack of adequate 
speech materials and suitable outcome measures for efficacy and effectiveness testing partially 
account for this. From the perspective of scientific evidence, the benefits of asynchronous SL 
telemedicine applications concern data storage and data analyses. To facilitate implementation 
of telemedicine, there is a call for development of information and communication technology 
infrastructures that allow feasible applications which meet requirements with regard to licensure 
and medical privacy laws. For applications with evidence for beneficial effects, we are challenged 
to develop new business models that apply to a new health care environment.
Keywords: telemedicine, speech, language, disorders, rehabilitation
Introduction
There are many speech-language (SL) disorders, ranging from stuttering and voice 
disorders to developmental apraxia, dysarthria, and aphasia. Treatment protocols and 
treatment effects vary to a large extent; evidence for specific treatments is not always 
available, and treatment is often age-specific. Apart from the content of treatment, the 
modes of health care delivery increasingly vary due to developments in information and 
communication technology. Based on these developments, telemedicine applications, 
allowing remote interventions in SL pathology, are gaining interest.
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Telemedicine in general may overcome barriers with regard 
to access to services caused by distance or impaired mobility.1 
In addition, the possibility of remote service delivery may be 
a solution to the threatening disbalance between the need for 
and availability of health care delivery in the years to come. 
That is, growing numbers of aging patients with chronic 
diseases, including neurologic conditions, are looking for 
high-quality health care in times of limited financial and thera-
peutic resources.2 For this reason, in the field of SL pathology, 
telemedicine applications may be particularly interesting for 
patients with SL disorders due to acquired neurologic diseases, 
such as stroke or Parkinson’s disease (PD).
The American Speech-Language-Hearing Association is 
the professional, scientific, and credentialing association for 
more than 173,000 SL pathologists, audiologists, and SL and 
hearing scientists in the USA and elsewhere. The position 
of the American Speech-Language-Hearing Association is 
that telehealth is an appropriate model of service delivery 
for the SL pathology profession. Indeed, SL pathologists are 
becoming increasingly aware of the potential of telemedicine 
applications and are being challenged to adopt these new 
technologies in clinical practice.3 Although the technologies 
allowing telemedicine applications are promising for innova-
tions in this field, we should take note of the following two 
issues. First, the use of telepractice does not remove any 
existing responsibilities in delivering services. Health care 
delivery by telemedicine technologies should meet the same 
requirements as those for traditional service delivery from 
the perspectives of quality of care and health care ethics.3 
Second, enthusiasm for telemedicine on the part of policy-
makers and health officials has not always been matched by 
uptake and utilization in practice. It is therefore crucial to 
identify barriers to and facilitators of implementation.4
In this paper, we discuss applications for remote treatment 
of patients with acquired SL pathology due to neurologic 
diseases in the context of a telemedicine taxonomy. This 
taxonomy may help to better understand the implications for 
stakeholders in health care with regard to expansion of these 
innovative products for SL pathology.5 We specifically focus 
on asynchronous telemedicine applications for dysarthria 
(ie, distorted speech production due to diminished force and 
coordination of speech muscles)6 and aphasia (ie, distorted 
language understanding and production).7
Telemedicine taxonomy
We adopt the approach of Bashshur et al,5 who provide a clear 
and concise multidimensional taxonomy for telemedicine. 
This taxonomy does justice to the variety of telemedicine, and 
helps to identify the precise nature of a specific  application. 
Thus, the confusion often caused by interchangeable use 
of terms like “telehealth”, “telemedicine”, “telecare”, and 
“telepractice” can be avoided.
The taxonomy comprises two levels. The first level is 
grouped into three dimensions. Based on this first level, each 
telecare application can be classified according to function-
ality, specific applications, and technologic configurations. 
Subsequently, the second classification level allows grouping 
according to the components, as described below.
Functionality
The functionality dimension refers to functions that are 
performed and allows classification into the aspects of the 
medical care process. Activities such as prevention, diagno-
sis, treatment, follow-up, and rehabilitation are grouped into 
the four following components:
•	 Consultation, eg, prevention
•	 Diagnosis, eg, assessment
•	 Monitoring, eg, rehabilitation in the patient’s home 
environment or telemetry for chronic patients with, for 
instance, diabetes
•	 Mentoring, eg, remote guidance of one specialist to 
another.
Specific applications
This dimension includes processes of care across basic (para)
medical specialties, and subspecializations based on disease 
entities, sites of care, and treatment modalities:
•	 Medical specialty, eg, neurology, rehabilitation 
medicine
•	 Disease, eg, stroke, PD
•	 Site of care, eg, home, outpatient center
•	 Treatment (modality), eg, SL therapy, physiotherapy.
Technologic configurations
•	 Network, ie, virtual private network, open Internet, social 
networks
•	 Connectivity, ie, wired or wireless
•	 Synchronicity, ie, synchronous or asynchronous.
Synchronous services are conducted with interactive audio 
and video connection in real time (ie,  videoconferencing). 
They create an in-person experience similar to that achieved 
in a traditional encounter. Synchronous services may connect 
a client/patient or group of clients/patients with a clinician, 
or they may include consultation between a clinician and a 
specialist. In asynchronous services, images or data are cap-
tured and transmitted (ie, stored and forwarded) for viewing 
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or interpretation by a professional. Examples include trans-
mission of voice clips, audiology testing results, or outcomes 
of independent client/patient practice.
Asynchronous telemedicine 
applications for acquired  
neurogenic SL disorders
Given the demand for equal quality of telemedicine compared 
with traditional health care services, there is an obvious need 
to prove the positive effects of telemedicine. This calls for 
data storage and data analyses, which fits with asynchronous 
technology. For this reason, in this paper on telemedicine in 
the rehabilitation of acquired neurogenic SL disorders, we 
focus on applications based on asynchronous technology.
We first give a short characterization of aphasia and 
dysarthria, being the most frequently occurring SL disorders 
after acquired neurologic diseases, and then review the most 
important developments with regard to telemedicine in this 
field. Finally, we discuss the challenges for implementation 
in (para) medical care.
Aphasia and dysarthria are the most common SL disor-
ders resulting from neurologic diseases, such as Parkinson’s 
disease (PD) stroke or traumatic brain injury.
Aphasia is a communication disorder that is usually 
acquired in adulthood and has to be distinguished from a 
(motor) speech disorder like dysarthria. The term “aphasia” 
encompasses a number of disturbances in the decoding 
of language and speech, in the generation of language, or 
both. Sometimes there is comorbidity, in the sense that both 
language production and speech production are affected.8 
The ultimate goal of aphasia therapy is to achieve a level 
of functional communication that enables the person with 
aphasia to participate in society. However, in many therapies, 
the focus is quite restricted and primarily aims at facilitating 
word finding.7,9
Unlike aphasia, dysarthria is not based on a language 
problem and has been defined as “a neurologic motor 
speech impairment that is characterized by slow, weak, 
imprecise, and/or uncoordinated movements of the speech 
 musculature”.10 Such impairment can result from damage to 
the central or peripheral nervous system.6
Both aphasia and dysarthria occur quite frequently after 
acquired neurologic diseases. The incidence of aphasia after 
stroke is estimated to be one third among those who survive.7 
Dysarthria after stroke occurs in about 50% of cases,11 and 
the reported incidence of dysarthria in PD varies from 50% 
to 90%. With these considerable incidences in mind, it is 
obvious that, in a time of limited therapeutic and financial 
resources, the potential benefits of telemedicine for aphasic 
and dysarthric patients are appealing. The possibility to 
intensify training, independent of the physical presence of 
a speech therapist, is considered a main advantage since 
there is ample evidence for the beneficial effects of inten-
sive training on communication rehabilitation.12 Apart from 
intensifying training, telemedicine also allows (independent) 
prolongation of training after discharge from therapy, with 
alleged positive effects on communication. With regard to 
aphasia, there is evidence that, although most recovery takes 
place in the first 6 months after stroke, people can continue 
to improve their language skills for several years.13 Also, for 
people with longstanding dysarthria resulting from stroke 
or PD, there is evidence that their speech can still improve 
with treatment.6,14
Below we review developments in telemedicine applica-
tions for aphasia and dysarthria.
Telemedicine in aphasia
The development of computer programs for the training 
of aphasic patients started some 15 years ago, as it makes 
intensive therapy possible.15 In most programs, a mixture of 
text, graphics, and audio stimuli is presented.16 It is generally 
recognized that the presentation of visual stimuli enhances 
the effects of therapy in aphasic patients, as it relieves work-
ing memory and provides training of this important part of 
the language processing system.17,18 Providing immediate 
feedback (instead of delayed feedback) is also known to 
enhance the effects of therapy.19
In telemedicine applications for aphasia, synchronous 
and asynchronous technology tends to be combined by using 
hybrid technology systems. Thus, the main advantages of 
synchronous (ie, real-time interaction by videoconferencing) 
and asynchronous (ie, intensive, independent training, stor-
age, and analyses of audio and video data) technology can 
be combined.20,21 For example, an aphasic patient is provided 
with a structured language intervention by asynchronous 
technology, while an SL pathologist is enabled to monitor 
real time by videoconferencing. Also, the possibility of only 
asynchronous language training is possible, with an SL 
pathology monitor or analyze the results asynchronously. 
An example is eREST (REduced Syntax Therapy), in which 
aphasic speakers with chronic agrammatism are stimulated 
to use elliptical constructions, and progress is assessed by 
a therapist.22
Although the above-mentioned teleapplications enable 
efficient, intensive, and individualized management of 
aphasia, the language training tends to be confined to a 
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highly structured therapy practice context. Some telemedicine 
applications aim at an even more restricted goal: stimulating 
word finding by providing pictures and alternative responses, 
with or without automatic speech recognition. However, since 
recovery of functional communication in daily life is most 
beneficial for aphasic patients, virtual training environments 
(VTEs) for aphasia therapy offer challenging possibilities and 
are rapidly gaining interest. A VTE is an artificial environ-
ment that is created with software and is presented to the user 
in such a way that it is accepted as a real  environment. In 
the case of aphasia therapy, a real environment is simulated 
for language training. A VTE allows patients to participate 
in social exchanges using a virtual character or “avatar” to 
represent themselves. Thus, they are allowed to develop 
communication skills and recreate a social environment to 
practice those skills. VTEs also have the potential to prevent 
social isolation since they create opportunities to create 
virtual encounters and may build up confidence for real-life 
social experiences. It is obvious that compliance with therapy 
may be enhanced by virtual training. Notwithstanding these 
potential applications, there are some technologic chal-
lenges with regard to the user interface required for aphasic 
patients to engage in VTEs. We will discuss these in some 
more detail.
Given the potential applications described above, 
VTEs for aphasia therapy should present all features that 
are characteristic of natural conversation, being visual 
presentation of a familiar environment and objects (eg, 
a shop, a home, objects of discourse) and autonomous 
agents that understand a patient’s speech, and can react 
appropriately, both in speech and by visual and oral back 
channeling. The interaction between agents and a patient 
is especially challenging, since this requires complex 
technologic interaction.
A VTE requires interaction between the patient and 
two autonomous agents (a virtual therapist and a virtual 
character with whom the patient must communicate). The 
therapist agent will guide the tasks of the patient (eg, offer-
ing instructions on how to proceed with the training). The 
second agent will engage in task-relevant communication 
with the patient. The virtual agents fit in a recent line of 
research on virtual characters, sometimes also referred to as 
“embodied  conversational agents”,23 “life-like characters”,24 
or “virtual humans”.25  Technically, such characters can be 
seen as an integration of SL technology with computer graph-
ics and artificial  intelligence. SL technology is required to 
automatically process a user’s input (ie, automatic speech 
recognition and natural language understanding), and to 
automatically produce the responses of the virtual character 
(ie, using natural language generation and speech synthe-
sis). Computer graphics are needed to visualize the virtual 
characters and to animate their behavior. In recent years, 
substantial progress has been made in integrating the various 
“enabling  technologies” for such virtual characters,26,27 and 
various applications have been developed. Artificial intel-
ligence is needed to enable the virtual characters to emulate 
the communicative behavior that patients would expect from 
real persons.
Recent research has shown that it is possible to develop 
artificial intelligence and dialogue management for conduct-
ing natural conversations with a virtual character.28 Rapid 
developments in Semantic Web technology (SWT) are 
expected to accelerate patients’ dynamic communicative 
interactions in VTEs which are materialized in increasingly 
varied forms. SWT is defined as “… an extension of the cur-
rent Web in which information is given well-defined meaning, 
better enabling computers and people to work in cooperation”. 
Once the Web has a mechanism for defining semantics about 
resources and links, then the possibility arises for automatic 
processing of the Web by software agents, rather than media-
tion by people.29,30 For example, in the case of VTE for aphasic 
patients, SWT would make it possible to generate target SL 
output on the basis of visual, auditory, or lexical features of 
objects or situations, based on semantic relationships with a 
possible target. However, SWT is not restricted to applications 
that are directly associated with the Web.
With regard to the automatic speech recognition used in 
VTEs for aphasic patients, there remain some challenges to 
be addressed. For example, while single-word recognition 
is not a difficult task for automatic speech recognition, the 
recognition of content units, which can vary both in length 
and wording, is difficult. It may not be robust enough for 
applications with patients, especially in the case of aphasia 
with comorbidity (dysarthria, apraxia of speech). That is 
why one can expect, in the near future, the development 
and application of more procedures that focus on word 
retrieval supported by sophisticated visual cues and scoring 
protocols. For a good example of such an approach, still 
without automatic speech recognition, we refer to the sys-
tem described by Palmer et al.7 They showed that computer 
therapy can be beneficial for word finding, but less so for 
people with longstanding aphasia. The complicating factor 
in this well designed study is, however, the definition of 
“usual care” assigned to their control group. Usual care 
may vary from country to country, and from one clinical 
setting to another.
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Telemedicine in dysarthria
Just like in aphasic patients, Palmer et al found evidence 
that patients with chronic dysarthria benefit to the same 
extent from (off-line) computerized therapy as from tradi-
tional face-to-face therapy.6 Given the indications for the 
beneficial effects of intensive speech training after stroke in 
chronic neurologic patients,11,14 the potential applications of 
telemedicine in dysarthria are obvious.12
Most studies reported on telemedicine for dysarthria 
concern videoconferencing and are primarily aimed at 
speech training in patients with PD31 according to the LSVT 
(Lee Silverman Voice Treatment), which aims at increased 
vocal loudness.32 Although this telemedicine application 
seems promising, a disadvantage obviously lies in the syn-
chronous technology, demanding the SL pathologist’s pres-
ence during treatment sessions.
An asynchronous application for Web-based speech train-
ing (e-learning-based speech therapy) allowing patients with 
dysarthria to train their speech in their home environment 
has been developed by Beijer et al.33 They concluded that 
this telemedicine application allows intensive, tailor-made 
speech training in the patient’s home environment as well 
as remote monitoring by SL pathologists.14
Dysarthric patients tended to appreciate the possibility 
of Web-based training, but usability should be adapted to 
the needs of this specific user group. Clinical outcomes 
research according to general standards should be conducted 
to support the alleged beneficial effects of Web-based speech 
training on intelligibility.34 A key benefit of an asynchronous 
store-and-forward application like e-learning-based speech 
therapy is the possibility of generating a Web-based database 
of dysarthric speech for therapeutic and research purposes.35 
One of the research goals concerns improving automatic 
speech recognition of dysarthric speech.
Like for aphasia, there is a growing interest in VTEs for 
dysarthria. That is, due to the repetitive nature of regular 
speech exercises (eg, drills) for dysarthric speech, compli-
ance with therapy is often lacking. This calls for motivat-
ing elements to improve compliance with speech therapy 
in patients who practice in their home environment. As in 
aphasia therapy, a VTE for dysarthria therapy should also 
represent features for natural conversation. In addition, auto-
matic recognition of dysarthric speech should be developed 
to  establish automatic feedback. This is a particularly chal-
lenging task for dysarthria, due to the variability of speech 
between and within dysarthric speakers.34 In the  Netherlands, 
an interactive game for speech training in dysarthric patients 
is currently being developed in the CHASING  (CHAllenging 
Speech training In Neurological patients by interactive Gam-
ing) project.36
Challenges for implementation
The rapid progress in information and communications 
technology and SL technology is clearly one of the reasons 
why thorough evaluation of their applications often lags 
behind their availability. In addition, lack of clarity regard-
ing the specific goals and target groups of telemedicine 
applications may hamper decision-making with regard to 
upscaling. Therefore, the relevance of positioning newly 
developed applications in a telemedicine taxonomy and 
classifying them with regard to functionality, applications, 
and technology is obvious. Establishing common features 
in varying telemedicine applications may elucidate shared 
interests of stakeholders in health care, and enhance upscaling 
and utilization.
It is obvious that the emergence of telemedicine affects 
all stakeholders in the health care landscape (Figure 1). The 
technologic innovations induce adaptations in health care 
processes, along with the need for a cultural shift in both 
health care professionals and patients. In addition, govern-
ment policy-makers and reimbursement companies have to 
reconsider measures to be taken to facilitate the adoption and 
upscaling of telemedicine.
Research
A key issue for accelerating telemedicine applications in the 
SL domain is the need for scientific evidence of their benefi-
cial effects. Once clinical outcomes research has confirmed 
the advantages for the health care domain, policy-makers 
and reimbursement companies are liable to take measures 
for rapid integration and scaling of these telemedicine 
applications. With the importance of scientific evidence in 
mind, implementation of telemedicine in the domain of SL 
disorders constitutes a true challenge. That is, research on 
the effects of therapies for SL pathology is not easy for a 
number of reasons:
•	 As the heterogeneity of groups of neurologic patients with 
aphasia and/or dysarthria is often quite high, large num-
bers of patients are needed in order to reach an acceptable 
test power. However, this is not always  possible (see under 
the next entry).38
•	 It is not always possible to find relatively large numbers 
of patients meeting specific requirements with regard 
to age, sex, severity of disease, time since onset, and 
socioeconomic status. This specifically holds for so-called 
small languages or minority languages.
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Figure 1 Stakeholders in the health care landscape. 
Note: Adapted with permission from Janssen R, Hettinga M, visser S, Menko R, Prins H, Krediet i, Haaker T Bodenstaff L. innovation routes and evidence guidelines for 
e-health small and medium-sized enterprises. Towards feasible yet convincing evidence. International Journal on Advances in Life Sciences. 2013;5(3,4):188–203.37
•	 As the number of participants may be quite small, one 
cannot assume that a random selection of patients yields 
unbiased samples. That is why randomized controlled 
trials are often not feasible.
•	 Matching patients in treatment and control groups is 
often a difficult task, and is sometimes problematic from 
a statistical and methodologic point of view.
•	 It is difficult to avoid the well-known Hawthorne effect, 
especially when traditional and new computer-based 
approaches are compared. Participants might show a 
positive bias both in attitude and level of activity when 
an approach is offered that is new to them.
•	 It is difficult to establish suitable outcome measures that 
reflect genuine within-subject changes in the speech and 
language of neurologic patients. Below, we elaborate 
further on therapeutic outcome measures for aphasia and 
dysarthria.
Outcome measures  
in aphasia therapy
Relevant outcomes in aphasia therapy are largely treatment-
dependent but also depend on the different types of aphasia 
and the time elapsed since the onset of the neurologic disease. 
The outcome measure of therapies aiming at facilitating word 
finding is relatively simple, ie, the number of words correctly 
associated with some picture, visual cue, or sound fragment. 
In some therapies, a relevant outcome is the realization of 
so-called content units, ie, parts of speech that are considered 
to be crucial for conveying a message.22 Detection of content 
units in the speech of persons with aphasia is not always 
easy, given that repetitions, nongrammatic expressions, and 
unexpected rephrasing can sometimes disturb the assessment 
procedures. Automatic detection of these units in spoken lan-
guage will put high demands on the SL technology to be used. 
It illustrates the problems encountered in many telemedicine 
applications for SL pathology: the lack of robustness of SL 
technology, interfering with the necessity to automatically 
assess features of atypical speech and language which are 
also difficult to be assessed by trained therapists.
Outcome measures  
in dysarthria therapy
The ultimate outcome measures in dysarthria therapy are 
intelligibility and comprehensibility. Intelligibility is signal-
driven and refers to speaker-dependent information (ie, the 
acoustic speech signal). Comprehensibility is the result of both 
speaker-dependent and speaker-independent  information. 
Speaker-independent information can be controlled by the 
speaker (eg, gestures) but may also be determined by the situ-
ational context.39 Intelligibility measurement in particular is 
not an easy task since it is a true challenge to find ecologically 
valid speech materials that are also suitable for the outcome 
measures corresponding to  intelligibility.34 That is, speech 
materials should reflect everyday conversation, but should 
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also contain target  elements that are sensitive to (acoustic) 
outcome measures corresponding to speech intelligibility. 
The quantity of speech assessment materials should also 
be taken into account. The enhancement of “environmental 
sensitivity” calls for larger amounts of speech materials, but 
the neurologic condition of dysarthric speakers does not allow 
long assessment sessions. Therefore, an adequate balance 
should be found between the need for enhanced sensitivity 
and the physical burden on dysarthric speakers. Apart from 
the type and speech materials for assessment, confounding 
variables such as ambient noise in home environments, should 
not affect measurements for intelligibility assessment.
Government policy
The World Health Organization challenges all governments 
to deliver better services to support health and well-being 
in order for people to live healthier and longer lives and 
to reduce inequalities in health care delivery. Health care 
delivery on the basis of telemedicine is one of the innovations 
that may contribute to the challenges of our aging population, 
which is characterized by increasingly demanding patients, 
a revolution of information, communication, and medical 
technology, and a call for care closer to home. It is important, 
particularly for the easily overlooked domain of SL therapy, to 
provide policy-makers with data and information to enhance 
well-informed decisions on telemedicine for SL disorders.11 
From this perspective, the need for scientific evidence in 
telemedicine applications is obvious and governments are 
challenged to fund scientific research in this field. Priority 
of research (and hence, funding policy) may be established 
along the dimensions and components of the telemedicine 
taxonomy described in this paper. Telemedicine taxonomy 
may also support policy-making with regard to (state) licen-
sure laws and medical information privacy laws.21
Reimbursement companies
It is clear that telemedicine for neurologic patients with SL 
disorders offers the potential to extend the continuum of 
care and improve the clinical outcomes for these patients. 
This is especially important from the perspective of insur-
ance reimbursement challenges and shortened durations of 
hospital stay.40
Reimbursement companies base their decisions on cost-
benefit analyses during a time of rapidly changing health 
care environments. Therefore, they should play an active 
role in the development of new business models that apply 
to new technology-based health care environments. Rather 
than actual cash savings, models that aim at efficiency gains 
should be implemented. This calls for a broad orientation 
regarding the interests of all stakeholders in the health 
care landscape. At this point, the relevance of telemedicine 
arises again. That is, an overview of common interests of 
stakeholders may be supported by grouping telemedicine 
applications in the taxonomy. Establishment of applications 
with common functionalities, technologies, and applications 
may enhance the development of new business models that 
apply to changing health care environments.
Health care institutions  
and patients (supported by patient  
and professional associations)
Due to limited financial resources, health care institutions 
tend to discharge neurologic patients from clinical care early, 
and are therefore challenged to provide their services in a dif-
ferent manner. Obviously, from this perspective, telemedicine 
is appealing. It allows health care professionals to remotely 
monitor and mentor neurologic patients in order to intensify 
and prolong SL pathology services after clinical discharge. In 
addition, telemedicine applications based on asynchronous 
technology allow data storage and data analyses, which 
are important for being able to meet the increasing call for 
transparent and evidence-based health care. Data storage and 
analyses are clearly of common interest to researchers, health 
care institutions, and reimbursement companies.
SL pathologists and patients seem similarly anxious to 
adopt telemedicine technology for communication disorders 
resulting from neurologic disease.1,21 However, to lower the 
threshold for using telemedicine, its applications should be 
adapted to users’ needs.41 Large user groups with common 
interests and needs may also be identified along the tele-
medicine taxonomy and serve as an argument for further 
development of telemedicine applications and new business 
models by reimbursement companies.
Companies
Companies delivering telemedicine technology should adapt 
their policies on product development to the common inter-
ests of health care institutions and patients. In addition, they 
should ensure the absence of interests that conflict with those 
of other stakeholders in order to successfully implement their 
innovative technology.37
Future directions and conclusion
The telemedicine taxonomy described in this paper provides 
the possibility for classification of different telemedicine 
developments along the dimensions of functionality, specific 
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applications, and technology, as well as their components. This 
classification provides an adequate basis upon which to group 
applications with common features, thus elucidating potential 
common interests (eg, asynchronous technology, remote assess-
ment of patients with chronic conditions) for different stake-
holders in health care. On the basis of stakeholders’ common 
interests in specific grouped applications, they can estimate the 
number of potential users, costs, and research needs, and make 
decisions aimed at accelerating genuine utilization (Figure 2). 
Stakeholders may compare the magnitudes of common interests 
in different groups of telemedicine applications to prioritize 
upscaling. For example, dependent on the largest common 
interests, they may choose for either applications  based on 
asynchronous technology for treatment of chronic neurologic 
patients with SL disorders in rehabilitation medicine, or for 
applications based on synchronous technology for stuttering 
patients who prefer web-based instead of face-to-face consults 
with their SL pathologist. The largest common interest of 
policy-makers, health care institutions, and reimbursement 
companies will be decisive. The research focus and policy-
making of companies regarding product development will 
partially depend on the priorities of other stakeholders.
The taxonomy dimension of technologic configurations 
is of key importance since it is closely associated with the 
technologic feasibility, financial investments, licensure 
laws, and (medical) information privacy laws of telemedi-
cine applications. A large common interest for the different 
stakeholders in the health care landscape therefore lies in the 
technologic infrastructure, and government policy-makers 
should take measures to stimulate the development of infra-
structures that apply to licensure and (medical) information 
privacy laws, reimbursement companies aim at infrastructures 
that guarantee optimal cost-benefit ratios (eg, preferably 
asynchronous applications). This elucidates the central role of 
information and communication technology companies, with 
development and delivery of technologic infrastructure as their 
core business, and the vital importance of these companies 
carefully considering the common interests of the different 
stakeholders in technology for telemedicine in SL disorders.
In fact, successful upscaling of newly developed telemedi-
cine applications requires collaboration of stakeholders to 
identify common interests and plan road maps for establish-
ing genuine utilization in a new health care environment.
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